April 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
Projections indicate that, the global anti-hypertensive drugs market will increase from USD 26.76 billion in 2025 to USD 39.2 billion by 2035, experiencing a CAGR of 3.89% over the next 10 years. Market growth is driven by the rising prevalence of hypertension, aging populations, and advancements in medications targeting blood pressure management. ...
April 21, 2026
Market insights predict, the branded generics industry is expected to grow from USD 383.1 billion in 2025 to USD 867.21 billion by 2035, driven by a CAGR of 8.47%. The branded generics market is growing due to the rising prevalence of chronic health conditions has increased demand for long-term drug therapies. North America is leading due to the st...
April 21, 2026
According to market projections, the lipid regulators sector is expected to grow from USD 33.65 billion in 2025 to USD 49.96 billion by 2035, reflecting a CAGR of 4.04%. The market is growing due to the rising prevalence of cardiovascular diseases and increasing awareness about cholesterol management. North America dominates the market owing to hig...
April 21, 2026
Market insights predict the global bone & joint health supplements industry will increase from USD 15.01 billion in 2025 to USD 34.04 billion by 2035, achieving a CAGR of 8.54%. The bone & joint health supplements market is growing due to rising osteoporosis cases. North America is leading the way due to rising arthritis cases....
April 21, 2026
Based on market forecasts, the global gene vector market, projected at USD 9.61 billion in 2025, is expected to reach USD 64.38 billion by 2035, growing at a CAGR of 21% over the forecast period. The gene vector market is growing due to rising demand for gene and cell therapy. North America’s dominance can be attributed to the rising demand f...
April 21, 2026
Based on market forecasts, the global fondaparinux market, projected at USD 721 million in 2025, is expected to reach USD 1419.61 million by 2035, growing at a CAGR of 6.36% over the forecast period. The increasing number of surgeries and growing research activities drive the global market. North America dominated the global market owing to the pre...
April 21, 2026
According to forecasts, the global protein chip market will grow from USD 2.36 billion in 2025 to USD 4.98 billion by 2035, with an expected CAGR of 7.78%.The market is driven by the rising demand for protein chips for diagnostics and personalized medicine applications. North America maintained a stronghold on the global market due to the strong pr...
April 21, 2026
Market insights predict the global gel documentation systems industry will increase from USD 373.9 million in 2025 to USD 683.1 million by 2035, achieving a CAGR of 6.21%. The market is driven by rising demand for high-resolution imaging and integration with cloud data management platforms....
April 21, 2026
According to market projections, the RNA analysis sector is expected to grow from USD 6.86 billion in 2025 to USD 23.9 billion by 2035, reflecting a CAGR of 13.36%. The RNA analysis market is growing due to increasing demand for personalized medicine. North America is leading due to its advanced research infrastructure and favorable government envi...
April 21, 2026
According to market projections, the global generic pharmaceuticals contract manufacturing market, valued at USD 81.24 billion in 2025, is anticipated to reach USD 143.22 billion by 2035, growing at a CAGR of 5.85% over the next decade. Day by day, the globe is increasingly demanding affordable drugs, including diverse biologics. North America regi...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com